Fny Investment Advisers, LLC Cerevel Therapeutics Holdings, Inc. Transaction History

Fny Investment Advisers, LLC

  • $194 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024
BUY
$38.96 - $42.75 $489,922 - $537,581
12,575 New
12,575 $514,000
Q4 2023

Jan 12, 2024
BUY
$20.27 - $42.44 $162,160 - $339,520
8,000 New
8,000 $339,000
Q1 2022

Apr 25, 2022
SELL
$23.5 - $35.38 $352 - $530
-15 Closed
0 $0
Q4 2021

Jan 10, 2022
BUY
$29.21 - $44.64 $438 - $669
15 New
15 $0

Others Institutions Holding CERE

# of Institutions
9
Shares Held
5.01M
Call Options Held
3.3K
Put Options Held
0
View Full List

About Cerevel Therapeutics Holdings, Inc.

CERE Quotes by TradingView
  • Ticker CERE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 155,752,000
  • Description
  • Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...
More about CERE
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email